|
Showing 1 - 7 of
7 matches in All Departments
This book challenges professional and public misconceptions of
schizophrenia as an illness with intractable symptoms and
inexorable mental deterioration, educating clinicians and
researchers on the effectiveness of treatment to change the course
of or prevent the onset of illness. The authors illustrate such
effectiveness through fifteen case studies examining psychosis in
diverse clients. These case studies are divided into the three
phases of the illness-prodromal/clinical high risk, first-episode,
chronic, and treatment-refractory-with accompanying analyses of the
causes, symptoms, interventions and treatments. By depicting
patients at different clinical stages of the illness, with
accompanying explanations of how they got to that point, what might
have been done to avoid - or has been done to achieve - this
outcome, the reader will gain an appreciation of the nature of the
illness and for the therapeutic potential of currently available
treatments. Readers will learn about the various clinical aspects
of schizophrenia and treatment including diagnosis, prognosis,
clinical presentation, suicide risk, cognitive deficits, stigma,
medication management, and psychosocial interventions.
This book challenges professional and public misconceptions of
schizophrenia as an illness with intractable symptoms and
inexorable mental deterioration, educating clinicians and
researchers on the effectiveness of treatment to change the course
of or prevent the onset of illness. The authors illustrate such
effectiveness through fifteen case studies examining psychosis in
diverse clients. These case studies are divided into the three
phases of the illness-prodromal/clinical high risk, first-episode,
chronic, and treatment-refractory-with accompanying analyses of the
causes, symptoms, interventions and treatments. By depicting
patients at different clinical stages of the illness, with
accompanying explanations of how they got to that point, what might
have been done to avoid - or has been done to achieve - this
outcome, the reader will gain an appreciation of the nature of the
illness and for the therapeutic potential of currently available
treatments. Readers will learn about the various clinical aspects
of schizophrenia and treatment including diagnosis, prognosis,
clinical presentation, suicide risk, cognitive deficits, stigma,
medication management, and psychosocial interventions.
A world-renowned psychiatrist reveals the fascinating story of
psychiatry's origins, demise and redemption. Psychiatry has come a
long way since the days of chaining 'lunatics' in cold cells and
parading them as freakish marvels before a gaping public. But, as
Jeffrey Lieberman reveals in his extraordinary and eye-opening
book, the path to legitimacy for 'the black sheep of medicine' has
been anything but smooth. In SHRINKS, Dr Lieberman traces the field
from its birth as a mystic pseudo-science through its adolescence
as a cult of 'shrinks' to its late blooming maturity since the
Second World War as a science-driven profession that saves lives.
With fascinating case studies and portraits of the luminaries of
the field, from Sigmund Freud to Eric Kandel, SHRINKS is a gripping
and illuminating read. It is also an urgent call-to-arms to dispel
the stigma surrounding mental illness and to start treating it as a
disease rather than a state of mind.
The body of knowledge that we have accumulated about the causes and
nature of schizophrenia is prodigious, and the repertoire of
evidence-based treatments is substantial and increasing.
Comprehensive Care of Schizophrenia distills this corpus into the
essential information that clinicians who care for persons with
schizophrenia need to know. The second edition of the popular
volume is thoroughly updated, offering new information on the
advances in research and management since the first edition was
published a decade ago. Chapters are streamlined to keep content as
concise as possible, while key sections have been revised and
expanded to include new information on drug therapy and advice on
patient care. People with schizophrenia can suffer from multiple
morbidities and disabilities, and thus may require a variety of
treatments, both pharmacological and psychosocial. To cover the
complex and growing field of schizophrenia management, renowned
psychiatrists Jeffrey Lieberman and Robin Murray have recruited a
distinguished group of researchers, practitioners and consumers of
mental health care. This guide delves into to all aspects of the
clinical management of schizophrenia for both the health care
professional who treats patients as well as the researcher
interested in the advances made in the field and their clinical
application.
Antipsychotic medications are a key treatment for schizophrenia and
sales of antipsychotic drugs approach $20 billion per year, with
fierce marketing between the makers of the drugs. The U.S. National
Institute of Mental Health sponsored the Clinical Antipsychotic
Trials of Intervention Effectiveness (CATIE) project to provide
independent information about the comparative effectiveness of
medications. CATIE was the largest, longest and most comprehensive
study of schizophrenia to date. Conducted under rigorous
double-blind conditions, Antipsychotic Trials in Schizophrenia
presents the definitive archival results of this landmark study.
The core of the book consists of chapters focused on specific
outcomes that set the CATIE findings in a wider context. Also
included are chapters on the design, statistical analyses and
implications for researchers, clinicians and policy makers.
Psychiatrists, psychiatric researchers, mental health policy makers
and those working in pharmaceutical companies will all find this to
be essential reading.
|
You may like...
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
|